CytoDyn, Inc. (CYDY)
0.20
0.00 (0.00%)
USD |
OTCM |
Oct 14, 16:00
CytoDyn Total Liabilities (Quarterly) : 117.13M for Aug. 31, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | 117.13M |
| May 31, 2026 | 123.69M |
| February 28, 2026 | 122.78M |
| November 30, 2025 | 128.68M |
| August 31, 2025 | 112.99M |
| May 31, 2025 | 114.09M |
| February 28, 2025 | 114.17M |
| November 30, 2024 | 114.27M |
| August 31, 2024 | 113.23M |
| May 31, 2024 | 127.89M |
| February 29, 2024 | 129.65M |
| November 30, 2023 | 123.62M |
| August 31, 2023 | 129.30M |
| May 31, 2023 | 120.79M |
| February 28, 2023 | 121.65M |
| November 30, 2022 | 123.04M |
| August 31, 2022 | 122.71M |
| May 31, 2022 | 123.58M |
| February 28, 2022 | 116.54M |
| November 30, 2021 | 116.40M |
| August 31, 2021 | 130.16M |
| May 31, 2021 | 153.10M |
| February 28, 2021 | 129.45M |
| November 30, 2020 | 150.30M |
| August 31, 2020 | 90.59M |
| Date | Value |
|---|---|
| May 31, 2020 | 52.99M |
| February 29, 2020 | 43.20M |
| November 30, 2019 | 31.55M |
| August 31, 2019 | 25.18M |
| May 31, 2019 | 29.79M |
| February 28, 2019 | 26.68M |
| November 30, 2018 | 28.45M |
| August 31, 2018 | 28.83M |
| May 31, 2018 | 18.06M |
| February 28, 2018 | 15.88M |
| November 30, 2017 | 19.28M |
| August 31, 2017 | 14.49M |
| May 31, 2017 | 9.159M |
| February 28, 2017 | 9.341M |
| November 30, 2016 | 10.30M |
| August 31, 2016 | 3.039M |
| May 31, 2016 | 3.581M |
| February 29, 2016 | 3.379M |
| November 30, 2015 | 9.270M |
| August 31, 2015 | 12.85M |
| May 31, 2015 | 15.37M |
| February 28, 2015 | 8.373M |
| November 30, 2014 | 7.352M |
| August 31, 2014 | 4.906M |
| May 31, 2014 | 4.505M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.05M |
| Shareholders Equity (Quarterly) | -98.07M |
| Debt to Equity Ratio | -0.2781 |
| Current Ratio | 0.382 |
| Net Debt Paydown Yield | 0.00% |